INS and obesity due to melanocortin 4 receptor deficiency: Our findings align with previous research indicating the beneficial role of PUFAs in modulating obesity risk through mechanisms such as improved lipid metabolism, enhanced insulin sensitivity, and anti-inflammatory effects [34,35,36].